Aspen Aerogels (NYSE:ASPN) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Aspen Aerogels' stock from "hold" to "strong sell." Barclays and Canaccord Genuity also lowered their target prices. The stock has an average "hold" rating and a target price of $12.67. Aspen Aerogels reported a quarterly loss, missing estimates, with revenue down 37.8% year-over-year. Institutional investors have adjusted their holdings, with 97.64% ownership. Aspen Aerogels designs aerogel insulation products for energy infrastructure and sustainable materials markets.
Aspen Aerogels (NYSE:ASPN - Get Free Report) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating in a research report issued on Monday,Zacks.com reports.
Other equities research analysts also recently issued research reports about the stock. Barclays dropped their target price on shares of Aspen Aerogels from $6.00 to $4.00 and set an "underweight" rating for the company in a research report on Friday, November 7th. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a "buy" rating for the company in a research report on Friday, November 7th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Aspen Aerogels in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $12.67.
Get Aspen Aerogels alerts:
Get Our Latest Stock Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 1.4%
ASPN opened at $3.62 on Monday. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The firm has a market cap of $299.18 million, a P/E ratio of -0.95 and a beta of 2.85. The business's fifty day simple moving average is $7.17 and its 200 day simple moving average is $6.75. Aspen Aerogels has a 52 week low of $3.47 and a 52 week high of $17.00.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.05). The company had revenue of $73.02 million during the quarter, compared to analysts' expectations of $73.42 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels's revenue for the quarter was down 37.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.17) earnings per share. Aspen Aerogels has set its FY 2025 guidance at -4.150--4.050 EPS. As a group, equities research analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current fiscal year.
Institutional Investors Weigh In On Aspen Aerogels
Large investors have recently modified their holdings of the stock. Teacher Retirement System of Texas purchased a new stake in shares of Aspen Aerogels during the first quarter valued at $65,000. Envestnet Asset Management Inc. raised its holdings in Aspen Aerogels by 17.5% during the 1st quarter. Envestnet Asset Management Inc. now owns 55,511 shares of the construction company's stock worth $355,000 after buying an additional 8,249 shares during the period. New York State Common Retirement Fund lifted its stake in Aspen Aerogels by 2,073.6% during the first quarter. New York State Common Retirement Fund now owns 437,572 shares of the construction company's stock valued at $2,796,000 after buying an additional 417,441 shares in the last quarter. CWM LLC boosted its holdings in shares of Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock worth $53,000 after buying an additional 7,953 shares during the period. Finally, AMH Equity Ltd purchased a new position in shares of Aspen Aerogels in the first quarter worth approximately $703,000. 97.64% of the stock is owned by institutional investors.
Aspen Aerogels Company Profile
(Get Free Report)Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles
- Five stocks we like better than Aspen Aerogels
- Best Energy Stocks - Energy Stocks to Buy Now
- Amazon Is One of the Clearest Buys If the Market Dips Again
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- CoreWeave's Guidance Cut: A Buying Opportunity in Disguise?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Aspen Aerogels Right Now?
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
